Search Results 1-10 of 27697 for methamphetamine

  1. Methamphetamine (Oral Route) Description and Brand Names - Mayo Clinic

    Methamphetamine is used to treat attention-deficit hyperactivity disorder (ADHD). ... Methamphetamine works in the treatment of ADHD by increasing attention and ...

  2. Methamphetamine (Oral Route) Proper Use - Mayo Clinic

    Methamphetamine works in the treatment of ADHD by increasing attention and decreasing restlessness in children and adults who are overactive, cannot concentrate ...

  3. Methamphetamine (Oral Route) Precautions - Mayo Clinic

    Withdrawal effects after stopping the medicine such as mental depression, nausea or vomiting, stomach cramps or pain, trembling, or unusual tiredness or ...

  4. Methamphetamine (Oral Route) Side Effects - Mayo Clinic

    Blurred vision · chest discomfort or pain · dark-colored urine · difficulty breathing · dizziness · faintness · false or unusual sense of wellbeing · fast, pounding, ...

  5. Methamphetamine (Oral Route) Before Using - Mayo Clinic

    Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of methamphetamine in the elderly.

  6. Methamphetamine (Oral Route) Proper Use - Mayo Clinic

    Methamphetamine (Oral Route) · Dosing. The dose of this medicine will be different for different patients. · Missed Dose. If you miss a dose of this medicine, ...

  7. Drug addiction (substance use disorder) - Symptoms and causes - Mayo Clinic

    Methamphetamine, opiates and cocaine are highly addictive and cause multiple short-term and long-term health consequences, including psychotic behavior ...

  9. Aspirin, Sodium Bicarbonate, And Citric Acid (Oral Route) Before Using - Mayo Clinic

    Methamphetamine; Methazolamide; Methotrexate; Methyclothiazide; Methylprednisolone; Metolazone; Milnacipran; Moexipril; Mometasone; Morniflumate; Nabumetone ...

  10. Publications - Chris C. Derauf, M.D. - Mayo Clinic

    School-Aged Outcomes following Prenatal Methamphetamine Exposure: 7.5-Year Follow-Up from the Infant Development, Environment, and Lifestyle Study. J Pediatr.